152 related articles for article (PubMed ID: 35566407)
1. Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia.
Kulis J; Wawrowski Ł; Sędek Ł; Wróbel Ł; Słota Ł; van der Velden VHJ; Szczepański T; Sikora M
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566407
[TBL] [Abstract][Full Text] [Related]
2. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
[TBL] [Abstract][Full Text] [Related]
3. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia.
Boris E; Theron A; Montagnon V; Rouquier N; Almeras M; Moreaux J; Bret C
Cytometry B Clin Cytom; 2024 Jan; 106(1):45-57. PubMed ID: 38037221
[TBL] [Abstract][Full Text] [Related]
6. NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of
Bisegna ML; Peragine N; Elia L; Matarazzo M; Milani ML; Intoppa S; Di Trani M; Malfona F; Martelli M; De Propris MS
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024018. PubMed ID: 38468826
[TBL] [Abstract][Full Text] [Related]
7. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
8. Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio.
Nagant C; Casula D; Janssens A; Nguyen VTP; Cantinieaux B
Int J Lab Hematol; 2018 Dec; 40(6):734-739. PubMed ID: 30113764
[TBL] [Abstract][Full Text] [Related]
9. Multicolor flow cytometry immunophenotyping and characterization of aneuploidy in pediatric B-cell precursor acute lymphoblastic leukemia.
Pierzyna-Świtała M; Sędek Ł; Kulis J; Mazur B; Muszyńska-Rosłan K; Kołtan A; Woszczyk M; Niedźwiecki M; Mizia-Malarz A; Karolczyk G; Lejman M; Trelińska J; Badowska W; Derwich K; Ociepa T; Malinowska I; Kazanowska B; Kowalczyk J; Szczepański T
Cent Eur J Immunol; 2021; 46(3):365-374. PubMed ID: 34764809
[TBL] [Abstract][Full Text] [Related]
10. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of blast immunophenotype between the diagnosis and relapse of childhood acute lymphoblastic leukaemia - implications for monitoring of minimal residual disease].
Bulsa J; Sedek Ł; Sońta-Jakimczyk D; Mazur B; Sobol G; Szczepański T
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1045-50. PubMed ID: 19531824
[TBL] [Abstract][Full Text] [Related]
12. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
[TBL] [Abstract][Full Text] [Related]
13. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
[TBL] [Abstract][Full Text] [Related]
14. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig WD
Ann Hematol; 1998 Sep; 77(3):107-14. PubMed ID: 9797079
[TBL] [Abstract][Full Text] [Related]
17. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
Chatterjee G; Sriram H; Ghogale S; Deshpande N; Khanka T; Panda D; Pradhan SN; Girase K; Narula G; Dhamane C; Malik NR; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 Jul; 100(4):434-445. PubMed ID: 32896101
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype.
Demina I; Zerkalenkova E; Illarionova O; Olshanskaya Y; Verzhbitskaya T; Semchenkova A; Tsaur G; Rusanova E; Belogurova M; Baidun L; Plyasunova S; Konyuhova T; Kazakova A; Fechina L; Novichkova G; Samochatova E; Myakova N; Maschan A; Popov AM
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2803-2811. PubMed ID: 31463716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
